Mobin Varghese

NPI: 1114504248
Total Payments
$3,138
2024 Payments
$1,479
Companies
28
Transactions
134
Medicare Patients
14
Medicare Billing
$1,815

Payment Breakdown by Category

Food & Beverage$3,137 (100.0%)
Education$1.01 (0.0%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,137 133 100.0%
Education $1.01 1 0.0%

Top Paying Companies

Company Total Records Latest Year
Veloxis Pharmaceuticals, Inc. $348.70 9 $0 (2024)
Amgen Inc. $313.23 12 $0 (2024)
Merck Sharp & Dohme LLC $298.35 13 $0 (2024)
Otsuka America Pharmaceutical, Inc. $264.65 13 $0 (2024)
AstraZeneca Pharmaceuticals LP $262.11 13 $0 (2024)
Horizon Therapeutics plc $254.77 10 $0 (2023)
Aurinia Pharma U.S., Inc. $199.94 9 $0 (2023)
Takeda Pharmaceuticals U.S.A., Inc. $192.64 8 $0 (2024)
Novo Nordisk Inc $156.55 7 $0 (2024)
CorMedix Inc. $155.45 6 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,479 62 Amgen Inc. ($280.70)
2023 $1,200 51 Horizon Therapeutics plc ($254.77)
2022 $458.62 21 Aurinia Pharma U.S., Inc. ($114.83)

All Payment Transactions

134 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
12/25/2024 CorMedix Inc. DefenCath (Drug) Food and Beverage In-kind items and services $24.25 General
Category: Catheter Lock Solution
12/17/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $23.06 General
Category: Inflammation/Rare Disease
12/12/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $21.59 General
Category: NEPHROLOGY
12/11/2024 CorMedix Inc. DefenCath (Drug) Food and Beverage In-kind items and services $28.20 General
Category: Catheter Lock Solution
11/21/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $22.77 General
Category: IMMUNOLOGY
11/20/2024 Merck Sharp & Dohme LLC PREVYMIS (Drug) Food and Beverage In-kind items and services $28.01 General
Category: INFECTIOUS DISEASE
11/19/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $19.30 General
Category: Inflammation/Rare Disease
11/19/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $19.10 General
Category: Inflammation/Rare Disease
11/14/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $16.72 General
Category: Cardio-renal
10/31/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $18.54 General
Category: Cardiovascular and Metabolism
10/23/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $18.51 General
Category: Inflammation/Rare Disease
10/16/2024 Merck Sharp & Dohme LLC PREVYMIS (Drug), DIFICID Food and Beverage In-kind items and services $23.73 General
Category: INFECTIOUS DISEASE
10/10/2024 OPKO Pharmaceuticals, LLC RAYALDEE (Drug) Food and Beverage In-kind items and services $21.49 General
Category: NEPHROLOGY
09/25/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $29.14 General
Category: Inflammation/Rare Disease
09/24/2024 Merck Sharp & Dohme LLC PREVYMIS (Drug) Food and Beverage In-kind items and services $19.31 General
Category: INFECTIOUS DISEASE
09/19/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $25.22 General
Category: IMMUNOLOGY
09/18/2024 Takeda Pharmaceuticals U.S.A., Inc. LIVTENCITY (Drug) Food and Beverage In-kind items and services $27.92 General
Category: IMMUNOLOGY
09/11/2024 Veloxis Pharmaceuticals, Inc. ENVARSUS (Drug) Food and Beverage In-kind items and services $32.15 General
Category: TRANSPLANTATION
09/10/2024 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $18.48 General
Category: Diabetes
09/10/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $14.77 General
Category: Rare Disease
08/29/2024 Otsuka Pharmaceutical Development & Commercialization, Inc. Food and Beverage In-kind items and services $17.45 General
08/28/2024 CorMedix Inc. DefenCath (Drug) Food and Beverage In-kind items and services $33.37 General
Category: Catheter Lock Solution
08/14/2024 Merck Sharp & Dohme LLC PREVYMIS (Drug), DIFICID Food and Beverage In-kind items and services $30.24 General
Category: INFECTIOUS DISEASE
08/13/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $25.90 General
Category: Inflammation/Rare Disease
08/01/2024 Novo Nordisk Inc Rivfloza (Drug) Food and Beverage In-kind items and services $24.47 General
Category: Rare Disease

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2022 1 14 15 $3,750 $1,815
Total Patients
14
Total Services
15
Medicare Billing
$1,815
Procedure Codes
1

All Medicare Procedures & Services

1 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 14 15 $3,750 $1,815 48.4%

About Mobin Varghese

Mobin Varghese is a Family healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2021. The National Provider Identifier (NPI) number assigned to this provider is 1114504248.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mobin Varghese has received a total of $3,138 in payments from pharmaceutical and medical device companies, with $1,479 received in 2024. These payments were reported across 134 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($3,137).

As a Medicare-enrolled provider, Varghese has provided services to 14 Medicare beneficiaries, totaling 15 services with total Medicare billing of $1,815. Data is available for 1 year (2022–2022), covering 1 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Other Specialties Nurse Practitioner
  • Location Dallas, TX
  • Active Since 03/25/2021
  • Last Updated 02/24/2022
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • NPI Number 1114504248

Products in Payments

  • KRYSTEXXA (Biological) $535.47
  • PREVYMIS (Drug) $298.35
  • ENVARSUS (Drug) $276.62
  • JYNARQUE (Drug) $264.65
  • LUPKYNIS (Drug) $199.94
  • LIVTENCITY (Drug) $192.64
  • DefenCath (Drug) $155.45
  • LOKELMA (Drug) $142.69
  • ACTHAR (Biological) $131.28
  • FARXIGA (Drug) $119.42
  • ULTOMIRIS (Biological) $116.79
  • Envarsus (Drug) $72.08
  • Ozempic (Drug) $69.00
  • Veltassa (Drug) $66.80
  • Rybelsus (Drug) $63.08
  • JARDIANCE (Drug) $51.56
  • Vascepa (Drug) $36.40
  • Parsabiv (Drug) $32.53
  • IBSRELA (Drug) $29.27
  • OXLUMO (Drug) $27.70

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Dallas